Frontlight ResearchEarly access
Trial site
MHAT National Heart Hospital EAD
- 4running trials
- 11closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- High blood pressure3 trials
- Multiple sclerosis3 trials
- Pulmonary arterial hypertension3 trials
- Stroke3 trials
- Atrial fibrillation2 trials
- Chronic kidney disease2 trials
- Coronary artery disease1 trial
- Heart failure1 trial
- Hyperparathyroidism1 trial
- Phase
- Phase 314 trials
- Phase 21 trial
- Status
- Completed11 trials
- Active, not recruiting4 trials
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- United Therapeutics2 trials
- Actelion1 trial
- AstraZeneca1 trial
- Bayer1 trial
- and 7 more
Running trials
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Closed trials
Completed
A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure
Completed
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Active, not recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026